Kyverna Therapeutics
KYTX
KYTX
75 hedge funds and large institutions have $136M invested in Kyverna Therapeutics in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 78 → 75 (-3)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
38% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 29
Holders
75
Holding in Top 10
3
Calls
$1.07M
Puts
$1K
Top Buyers
| 1 | +$1.51M | |
| 2 | +$886K | |
| 3 | +$783K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$672K |
| 5 |
Jane Street
New York
|
+$666K |
Top Sellers
| 1 | -$1.91M | |
| 2 | -$1.85M | |
| 3 | -$745K | |
| 4 |
Goldman Sachs
New York
|
-$559K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$524K |
